L1 Syndrome Latest Advances

Find the Latest Research About L1 Syndrome

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 366 publications

The emerging role of immunotherapy in improving outcomes in Down syndrome - associated acute lymphoblastic leukemia: an insightful review.

The emerging role of immunotherapy in improving outcomes in Down syndrome - associated acute lymphoblastic leukemia: an insightful review.

Journal: Leukemia & lymphoma
Published: November 20, 2025

Structural birth defects and leukemia risk in children with Down syndrome.

Structural birth defects and leukemia risk in children with Down syndrome.

Journal: Scientific reports
Published: October 21, 2025

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

Journal: American journal of human genetics
Published: August 13, 2025

Does Down syndrome affect the prognosis of acute lymphoblastic leukemia? A systematic review and meta-analysis.

Does Down syndrome affect the prognosis of acute lymphoblastic leukemia? A systematic review and meta-analysis.

Journal: Expert review of hematology
Published: July 28, 2025

Lifetime risk of solid tumors and leukemia in Down Syndrome: a population-based Swedish matched cohort study.

Lifetime risk of solid tumors and leukemia in Down Syndrome: a population-based Swedish matched cohort study.

Journal: British journal of cancer
Published: July 02, 2025

Moyamoya Syndrome in Patients With Down Syndrome and Acute Lymphoblastic Leukemia.

Moyamoya Syndrome in Patients With Down Syndrome and Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer
Published: May 28, 2025

Extramedullary Relapse of Acute B-Lymphoblastic Leukemia Leading to Paraplegia in a Child with Down Syndrome.

Extramedullary Relapse of Acute B-Lymphoblastic Leukemia Leading to Paraplegia in a Child with Down Syndrome.

Journal: Clinical laboratory
Published: April 10, 2025

Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.

Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.

Journal: Scientific reports
Published: March 20, 2025

Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature.

Transient Myeloproliferative Disorder (TMD), Acute Lymphoblastic Leukemia (ALL), and Juvenile Myelomonocytic Leukemia (JMML) in a Child with Noonan Syndrome: Sequential Occurrence, Single Center Experience, and Review of the Literature.

Journal: Genes
Published: August 16, 2024

Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia.

Inotuzumab ozogamicin for relapse prevention in a boy with Down syndrome and relapsed acute lymphoblastic leukemia.

Journal: International journal of hematology
Published: August 06, 2024

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia.

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia.

Journal: Leukemia
Published: June 28, 2024

Clinical and Molecular Genetic Analyses of a Girl With Isolated Nephrogenic Diabetes Insipidus due to Contiguous Gene Deletion Involving AVPR2 and L1CAM.

Clinical and Molecular Genetic Analyses of a Girl With Isolated Nephrogenic Diabetes Insipidus due to Contiguous Gene Deletion Involving AVPR2 and L1CAM.

Journal: American journal of medical genetics. Part A
Published: June 25, 2024
Showing 1-12 of 366

Last Updated: 04/28/2026